Eli Liebman

504 total citations
21 papers, 301 citations indexed

About

Eli Liebman is a scholar working on Economics and Econometrics, General Health Professions and Health. According to data from OpenAlex, Eli Liebman has authored 21 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 12 papers in General Health Professions and 4 papers in Health. Recurrent topics in Eli Liebman's work include Healthcare Policy and Management (14 papers), Global Health Care Issues (10 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Eli Liebman is often cited by papers focused on Healthcare Policy and Management (14 papers), Global Health Care Issues (10 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Eli Liebman collaborates with scholars based in United States, Australia and Canada. Eli Liebman's co-authors include Abe Dunn, Adam Hale Shapiro, Ana Aizcorbe, David B. Ridley, David Cutler, Adam B. Rosen, Michael E. Chernew, Bryan Bollinger, Jocelyn Sacco and Erin Hobin and has published in prestigious journals such as Journal of Marketing Research, Health Affairs and Journal of Health Economics.

In The Last Decade

Eli Liebman

20 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Liebman United States 9 157 117 70 31 22 21 301
Brett Wendling United States 9 207 1.3× 125 1.1× 24 0.3× 37 1.2× 47 2.1× 17 377
Ethan M.J. Lieber United States 10 162 1.0× 88 0.8× 96 1.4× 33 1.1× 52 2.4× 17 326
Harry Telser Switzerland 10 247 1.6× 146 1.2× 38 0.5× 13 0.4× 13 0.6× 26 384
Abby Swanson Kazley United States 12 106 0.7× 209 1.8× 53 0.8× 8 0.3× 20 0.9× 20 517
Ben Reason Canada 8 75 0.5× 70 0.6× 21 0.3× 71 2.3× 26 1.2× 11 307
Catherine Kastanioti Greece 10 114 0.7× 90 0.8× 29 0.4× 6 0.2× 20 0.9× 26 293
Boris Augurzky Germany 11 207 1.3× 197 1.7× 29 0.4× 6 0.2× 12 0.5× 50 397
Darren E. Ƶinner United States 12 189 1.2× 137 1.2× 127 1.8× 13 0.4× 12 0.5× 19 461
Jonathan Levin United States 8 193 1.2× 145 1.2× 130 1.9× 21 0.7× 94 4.3× 19 416
Jonathan Liberman Australia 11 97 0.6× 63 0.5× 89 1.3× 4 0.1× 32 1.5× 23 375

Countries citing papers authored by Eli Liebman

Since Specialization
Citations

This map shows the geographic impact of Eli Liebman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Liebman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Liebman more than expected).

Fields of papers citing papers by Eli Liebman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Liebman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Liebman. The network helps show where Eli Liebman may publish in the future.

Co-authorship network of co-authors of Eli Liebman

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Liebman. A scholar is included among the top collaborators of Eli Liebman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Liebman. Eli Liebman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liebman, Eli, et al.. (2023). Consequences of a shortage and rationing: Evidence from a pediatric vaccine. Journal of Health Economics. 92. 102819–102819. 3 indexed citations
2.
Liebman, Eli, et al.. (2021). Why do narrow network plans cost less?. Health Economics. 30(10). 2437–2451. 4 indexed citations
3.
Bollinger, Bryan, Eli Liebman, David Hammond, Erin Hobin, & Jocelyn Sacco. (2020). Educational Campaigns for Product Labels: Evidence from On-Shelf Nutritional Labeling. Journal of Marketing Research. 59(1). 153–172. 18 indexed citations
4.
Bollinger, Bryan, David Hammond, Erin Hobin, Eli Liebman, & Jocelyn Sacco. (2019). Do Educational Campaigns for On-Shelf Nutritional Labeling Work?. SSRN Electronic Journal. 2 indexed citations
5.
Liebman, Eli. (2018). Bargaining in Markets with Exclusion: An Analysis of Health Insurance Networks. 22 indexed citations
6.
Hobin, Erin, Bryan Bollinger, Jocelyn Sacco, et al.. (2017). Consumers’ Response to an On‐Shelf Nutrition Labelling System in Supermarkets: Evidence to Inform Policy and Practice. Milbank Quarterly. 95(3). 494–534. 51 indexed citations
7.
Yürükoğlu, Ali, Eli Liebman, & David B. Ridley. (2017). The Role of Government Reimbursement in Drug Shortages. American Economic Journal Economic Policy. 9(2). 348–382. 24 indexed citations
8.
Rosen, Allison B., Ana Aizcorbe, Tina Highfill, et al.. (2016). Attribution of Health Care Costs to Diseases: Does the Method Matter?. NBER Chapters. 76. 173–210. 1 indexed citations
9.
Ridley, David B., Xiaoshu Bei, & Eli Liebman. (2016). No Shot: US Vaccine Prices And Shortages. Health Affairs. 35(2). 235–241. 13 indexed citations
10.
Ridley, David B., Xiaoshu Bei, & Eli Liebman. (2016). No Shot: US Vaccine Prices and Shortages. SSRN Electronic Journal. 1 indexed citations
11.
Dunn, Abe, et al.. (2014). Defining Disease Episodes and the Effects on the Components of Expenditure Growth. RePEc: Research Papers in Economics. 6 indexed citations
12.
Dunn, Abe, Eli Liebman, & Adam Hale Shapiro. (2014). NCRN Meeting Fall 2014: Decomposing Medical-Care Expenditure Growth. eCommons (Cornell University). 1 indexed citations
13.
Dunn, Abe, Eli Liebman, & Adam Hale Shapiro. (2014). Implications of Utilization Shifts on Medical‐care Price Measurement. Health Economics. 24(5). 539–557. 2 indexed citations
14.
Dunn, Abe, Eli Liebman, & Adam Hale Shapiro. (2013). Developing a Framework for Decomposing Medical-Care Expenditure Growth: Exploring Issues of Representativeness. NBER Chapters. 545–574. 4 indexed citations
15.
Dunn, Abe, Adam Hale Shapiro, & Eli Liebman. (2013). Geographic variation in commercial medical-care expenditures: A framework for decomposing price and utilization. Journal of Health Economics. 32(6). 1153–1165. 18 indexed citations
16.
Aizcorbe, Ana, et al.. (2013). Alternative Price Indexes for Medical Care: Evidence from the MEPS Survey. RePEc: Research Papers in Economics. 9 indexed citations
17.
Aizcorbe, Ana, et al.. (2012). Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data. Statistical Journal of the IAOS. 28(1-2). 43–51. 70 indexed citations
18.
Aizcorbe, Ana, Eli Liebman, David Cutler, & Adam B. Rosen. (2012). Household Consumption Expenditures for Medical Care: An Alternate Presentation. 3 indexed citations
19.
Dunn, Abe, et al.. (2012). Decomposing Medical-Care Expenditure Growth. Federal Reserve Bank of San Francisco, Working Paper Series. 1–31. 8 indexed citations
20.
Dunn, Abe, et al.. (2012). Medical Care Price Indexes for Patients with Employer‐Provided Insurance: Nationally Representative Estimates from MarketScan Data. Health Services Research. 48(3). 1173–1190. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026